Haplogen is a privately held biotechnology company based on an entirely novel genetics technology platform. Its goal is to combat infectious diseases.
Despite improved hygiene and successful vaccination programs, infectious diseases remain a major cause of morbidity and mortality. Emerging resistance to conventional drugs and a lack of scientific tools further add to this immense medical and socioeconomic problem.
Our mission is to identify novel pathogen host factors using our proprietary technology and thereby develop therapeutics to treat infectious diseases.
Download fact sheet